Use of oxytocin and misoprostol for induction or ... - POPPHI
Use of oxytocin and misoprostol for induction or ... - POPPHI
Use of oxytocin and misoprostol for induction or ... - POPPHI
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
41. Weeks A, Alfirevic Z, Faúndes A, H<strong>of</strong>meyr GJ, Safar P, Wing D. Misoprostol <strong>f<strong>or</strong></strong><br />
<strong>induction</strong> <strong>of</strong> lab<strong>or</strong> with a live fetus. International Journal <strong>of</strong> Gynecology <strong>and</strong> Obstetrics.<br />
2007 [cited 1 January 2008];99(SUPPL. 2):S194-7.<br />
42. Sanchez-Ramos L, Danner CJ, Delke I, Kaunitz AM. The effect <strong>of</strong> tablet moistening<br />
on lab<strong>or</strong> <strong>induction</strong> with intravaginal <strong>misoprostol</strong>: A r<strong>and</strong>omized trial. Obstetrics <strong>and</strong><br />
Gynecology. 2002 [cited 10 December 2007];99(6):1080-4.<br />
43. Sanchez-Ramos L, Kaunitz AM. Misoprostol <strong>f<strong>or</strong></strong> cervical ripening <strong>and</strong> lab<strong>or</strong><br />
<strong>induction</strong>: A systematic review <strong>of</strong> the literature. Clinical Obstetrics <strong>and</strong> Gynecology.<br />
2000 [cited 10 December 2007];43(3):475-88.<br />
44. Ob<strong>or</strong>o VO, Isawumi AI, Akinola SE, Komolafe JO, Tijani AM, Adesina AO. Fact<strong>or</strong>s<br />
predicting failure <strong>of</strong> labour <strong>induction</strong>. Niger Postgrad Med J. 2007 Jun;14(2):137-9.<br />
45. Mauldin JG, Newman RB. Pri<strong>or</strong> cesarean: A contraindication to lab<strong>or</strong> <strong>induction</strong> Clin<br />
Obstet Gynecol. 2006 Sep;49(3):684-97.<br />
46. Lin C, Rayn<strong>or</strong> BD. Risk <strong>of</strong> uterine rupture in lab<strong>or</strong> <strong>induction</strong> <strong>of</strong> patients with pri<strong>or</strong><br />
cesarean section: An inner city hospital experience. Am J Obstet Gynecol. 2004<br />
May;190(5):1476-8.<br />
47. Ravasia DJ, Wood SL, Pollard JK. Uterine rupture during induced trial <strong>of</strong> lab<strong>or</strong><br />
among women with previous cesarean delivery. Am J Obstet Gynecol. 2000<br />
Nov;183(5):1176-9.<br />
48. Oscarsson ME, Amer-Wåhlin I, Rydhstroem H, Källén K. Outcome in obstetric care<br />
related to <strong>oxytocin</strong> use. A population-based study. Acta Obstetricia et Gynecologica<br />
Sc<strong>and</strong>inavica. 2006 [cited 13 January 2008];85(9):1094-8.<br />
49. National birth statistics [homepage on the Internet]. . 2007. Available from:<br />
http://www.achs.<strong>or</strong>g.au/display.aspxPageID=0&MemberID=0&screenwidth=1280#.<br />
50. Blondel B, Bréart G, Du Mazaubrun C, Badeyan G, Wcislo M, L<strong>or</strong>dier A, et al. The<br />
perinatal situation in france. evolution between 1981 <strong>and</strong> 1995. Journal de Gynecologie<br />
Obstetrique et Biologie de la Reproduction. 1997 [cited 5 December 2007];26(8):770-80.<br />
51. Births in scottish hospitals, year ending 3 may 2004 [homepage on the Internet]. .<br />
2004. Available from: http://www.isdscotl<strong>and</strong>.<strong>or</strong>g.<br />
52. Rep<strong>or</strong>t on maternity: Maternal <strong>and</strong> newb<strong>or</strong>n in<strong>f<strong>or</strong></strong>mation 2004 [homepage on the<br />
Internet]. . Available from: http://www.nzhis.govt.nz/moh.nsf/pagesns/73.<br />
53. Martin JA, Hamilton BE, Sutton PD, Ventura SJ, Menacker F, Kirmeyer S. Births:<br />
Final data <strong>f<strong>or</strong></strong> 2004. Natl Vital Stat Rep. 2006 Sep 29;55(1):1-101.<br />
54. Public Health Agency <strong>of</strong> Canada. Canadian perinatal health rep<strong>or</strong>t 2003. 2003.<br />
67
Change language